Trial
NCT02276560
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
—
Condition
Stage IIIA Non-Small Cell Lung Cancer
Intervention
Neoadjuvant Cisplatin, nab-paclitaxel
Why stopped
This study was terminated due to lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-11